Details for 2013762703
Up to date per 01.04.2026
Actions
Details for 2013762703
Granted/Registered
European Patent
15.07.2015 A
16.08.2017 B1
10.09.2012
US
201261699038 P
20.11.2012
US
201261728693 P
14.03.2013
US
201361782605 P
C07D 487/04 20060101AFI20140327BHEP
Owner
Principia Biopharma Inc.400 East Jamie Court, Suite 302 South San Francisco, CA 94080US
Representative
Representative
HÄUPL & ELLMEYER KG PATENTANWALTSKANZLEIMariahilfer Straße 501070 WienAT
Inventor
OWENS, Timc/o Principia Biopharma Inc. 400 East Jamie Court Suite 302 South San Francisco California 94080US
VERNER, Erik1521 Notre Dame Avenue Belmont, CA 94002US
Information about Fees